Systematic analysis of microRNA expression of RNA extracted from fresh frozen and formalin-fixed paraffin-embedded samples Y Xi, GO Nakajima, E Gavin, CG Morris, K Kudo, K Hayashi, J Ju Rna 13 (10), 1668-1674, 2007 | 713 | 2007 |
The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis AI Riker, SA Enkemann, O Fodstad, S Liu, S Ren, C Morris, Y Xi, P Howell, ... BMC medical genomics 1, 1-16, 2008 | 580 | 2008 |
MicroRNA-125b confers the resistance of breast cancer cells to paclitaxel through suppression of pro-apoptotic Bcl-2 antagonist killer 1 (Bak1) expression M Zhou, Z Liu, Y Zhao, Y Ding, H Liu, Y Xi, W Xiong, G Li, J Lu, O Fodstad, ... Journal of Biological Chemistry 285 (28), 21496-21507, 2010 | 498 | 2010 |
Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells B Song, Y Wang, Y Xi, K Kudo, S Bruheim, GI Botchkina, E Gavin, Y Wan, ... Oncogene 28 (46), 4065-4074, 2009 | 473 | 2009 |
Prognostic values of microRNAs in colorectal cancer Y Xi, A Formentini, M Chien, DB Weir, JJ Russo, J Ju, M Kornmann, J Ju Biomarker insights 1, 117727190600100009, 2006 | 438 | 2006 |
Non-coding microRNAs hsa-let-7g and hsa-miR-181b are associated with chemoresponse to S-1 in colon cancer GO Nakajima, K Hayashi, Y Xi, K Kudo, K Uchida, KEN Takasaki, ... Cancer genomics & proteomics 3 (5), 317-324, 2006 | 388 | 2006 |
MiR-200, a new star miRNA in human cancer X Feng, Z Wang, R Fillmore, Y Xi Cancer letters 344 (2), 166-173, 2014 | 384 | 2014 |
Differentially regulated micro-RNAs and actively translated messenger RNA transcripts by tumor suppressor p53 in colon cancer Y Xi, R Shalgi, O Fodstad, Y Pilpel, J Ju Clinical cancer research 12 (7), 2014-2024, 2006 | 267 | 2006 |
CRISPR/cas9, a novel genomic tool to knock down microRNA in vitro and in vivo H Chang, B Yi, R Ma, X Zhang, H Zhao, Y Xi Scientific reports 6 (1), 22312, 2016 | 256 | 2016 |
miR-192 Regulates dihydrofolate reductase and cellular proliferation through the p53-microRNA circuit B Song, Y Wang, K Kudo, EJ Gavin, Y Xi, J Ju Clinical Cancer Research 14 (24), 8080-8086, 2008 | 200 | 2008 |
Hypoxia-regulated microRNAs in human cancer G Shen, X Li, Y Jia, GA Piazza, Y Xi Acta Pharmacologica Sinica 34 (3), 336-341, 2013 | 169 | 2013 |
MiR-181 mediates cell differentiation by interrupting the Lin28 and let-7 feedback circuit X Li, J Zhang, L Gao, S McClellan, MA Finan, TW Butler, LB Owen, ... Cell Death & Differentiation 19 (3), 378-386, 2012 | 152 | 2012 |
Systematic evaluation of three microRNA profiling platforms: microarray, beads array, and quantitative real-time PCR array B Wang, P Howel, S Bruheim, J Ju, LB Owen, O Fodstad, Y Xi PloS one 6 (2), e17167, 2011 | 134 | 2011 |
Sulindac selectively inhibits colon tumor cell growth by activating the cGMP/PKG pathway to suppress Wnt/β-catenin signaling N Li, Y Xi, HN Tinsley, E Gurpinar, BD Gary, B Zhu, Y Li, X Chen, ... Molecular cancer therapeutics 12 (9), 1848-1859, 2013 | 132 | 2013 |
Large isoform of MRJ (DNAJB6) reduces malignant activity of breast cancer A Mitra, RA Fillmore, BJ Metge, M Rajesh, Y Xi, J King, J Ju, L Pannell, ... Breast Cancer Research 10, 1-13, 2008 | 114 | 2008 |
Growth of cancer cell lines under stem cell-like conditions has the potential to unveil therapeutic targets G Rappa, J Mercapide, F Anzanello, L Prasmickaite, Y Xi, J Ju, O Fodstad, ... Experimental cell research 314 (10), 2110-2122, 2008 | 88 | 2008 |
Panepoxydone targets NF-kB and FOXM1 to inhibit proliferation, induce apoptosis and reverse epithelial to mesenchymal transition in breast cancer R Arora, C Yates, BD Gary, S McClellan, M Tan, Y Xi, E Reed, GA Piazza, ... PLoS One 9 (6), e98370, 2014 | 85 | 2014 |
Sulindac inhibits tumor cell invasion by suppressing NF-κB-mediated transcription of microRNAs X Li, L Gao, Q Cui, BD Gary, DL Dyess, W Taylor, LA Shevde, RS Samant, ... Oncogene 31 (48), 4979-4986, 2012 | 85 | 2012 |
Nmi (N‐Myc interactor) inhibits Wnt/β‐catenin signaling and retards tumor growth RA Fillmore, A Mitra, Y Xi, J Ju, J Scammell, LA Shevde, RS Samant International journal of cancer 125 (3), 556-564, 2009 | 85 | 2009 |
A novel sulindac derivative that potently suppresses colon tumor cell growth by inhibiting cGMP phosphodiesterase and β-catenin transcriptional activity JD Whitt, N Li, HN Tinsley, X Chen, W Zhang, Y Li, BD Gary, AB Keeton, ... Cancer prevention research 5 (6), 822-833, 2012 | 79 | 2012 |